State of the science on mild cognitive impairment (MCI)

Mild cognitive impairment (MCI) represents a transitional stage between healthy aging and dementia, and affects 10–15% of the population over the age of 65. The failure of drug trials in Alzheimer’s disease (AD) treatment has shifted researchers’ focus toward delaying progression from MCI to dementi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	CNS spectrums Jg. 24; H. 1; S. 78 - 87
1. Verfasser:	Anderson, Nicole D.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Cambridge University Press 01.02.2019
Schlagworte:	Alzheimer's disease Apolipoproteins - genetics Apolipoproteins - metabolism Biomarkers Cognitive Dysfunction - drug therapy Cognitive Dysfunction - genetics Cognitive Dysfunction - metabolism Cognitive Dysfunction - physiopathology Cortical Excitability Humans Mental depression Nootropic Agents - therapeutic use Older people neuropsychological assessment exercise and diet interventions biomarkers tau Amyloid mild cognitive impairment memory strategy training neuroimaging
ISSN:	1092-8529, 2165-6509
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!